Dissociative Disorders in Obesity (Dissobe)
Dissobe
1 other identifier
observational
240
1 country
1
Brief Summary
THe aim of this study is to determine the frequency of dissociative tendencies in the obese population treated at the CELIOBE (Liberal Center for Obesity Support) at Hôpital Privé La Louvière among patients consulting for the first time and looking for a medical or surgical course. The DES scale of Carlson and Putman will be used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2019
CompletedFirst Submitted
Initial submission to the registry
October 4, 2021
CompletedFirst Posted
Study publicly available on registry
October 18, 2021
CompletedOctober 18, 2021
October 1, 2021
2 months
October 4, 2021
October 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
The degree of dissociative tendencies
The degree of dissociative tendencies measured by the Carlson and Putman DES scale.
1 day
Study Arms (2)
Obese patient following a medical course
Obese patient following a surgical course
Interventions
Questionnaires for the assessment of dissociative disorders in obese patients : DES scale of Carlson and Putman, SDQ-20 of Nijenhuis, comorbidities, Dutch Eating Behaviour Questionnaire (DEBQ), questionnaire of Rosenberg
Eligibility Criteria
Obese population with a body mass index over 30kg/m2 Minimum age : 18 years-old Patients consulting for the first time at CELIOBE and wishing a medical or surgical course.
You may qualify if:
- Age over 18
- Obesity defined by a Body Mass Index (BMI) ≥ 30 kg / m2
- Patient seen in consultation at CELIOBE for the first time for the management of an overweight problem, wishing for surgical or medical care
- Patient having been informed and not opposing to this research
- Patient affiliated or beneficiary of a social security scheme
You may not qualify if:
- Psychotic antecedents: Schizophrenia, Schizoaffective disorders, Hallucinatory psychoses, Brief psychotic attacks
- Addictive behaviors (alcohol, drug addiction)
- Drug use
- Taking antipsychotics and mood stabilizers
- Dissociative identity disorders proven
- Bipolar disorders or severe mental illness
- Understanding troubles
- Protected patient: Major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; Hospitalized without consent
- Pregnant, breastfeeding or parturient woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ramsay Générale de Santélead
- European Clinical Trial Experts Networkcollaborator
Study Sites (1)
Hôpital privé La Louvière
Lille, Haut de France, 59800, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2021
First Posted
October 18, 2021
Study Start
May 5, 2019
Primary Completion
July 5, 2019
Study Completion
December 5, 2019
Last Updated
October 18, 2021
Record last verified: 2021-10